{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:00:00Z","timestamp":1793451600664,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.ygyno.2006.04.004","type":"journal-article","created":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T02:55:54Z","timestamp":1149648954000},"page":"599-603","source":"Crossref","is-referenced-by-count":21,"title":["Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors"],"prefix":"10.1016","volume":"103","author":[{"given":"Giancarlo","family":"Garuti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvia","family":"Cellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Centinaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Nalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Luerti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2006.04.004_bib1","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1200\/JCO.2001.19.10.2596","article-title":"Superior efficacy of letrozole (Femara) versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase II study of the international letrozole breast cancer group","volume":"19","author":"Mouridsen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2006.04.004_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer","volume":"365","author":"ATAC Trialists Group","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2006.04.004_bib3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomised trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer","volume":"350","author":"Coombes","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2006.04.004_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.2005.04.120","article-title":"Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole trial","volume":"23","author":"Boccardo","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2006.04.004_bib5","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after five years therapy for early-stage breast cancer","volume":"349","author":"Goss","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2006.04.004_bib6","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1200\/JCO.1998.16.2.779","article-title":"Does tamoxifen cause cancer in humans?","volume":"16","author":"Stearns","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2006.04.004_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-200022010-00001","article-title":"Guidelines for monitoring patients taking tamoxifen treatment","volume":"22","author":"Neven","year":"2000","journal-title":"Drug Safety"},{"key":"10.1016\/j.ygyno.2006.04.004_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/gyno.2000.5876","article-title":"Limited value of sonohysterography for endometrial screening in asymptomatic postmenopausal patients treated with tamoxifen","volume":"78","author":"Bertelli","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.04.004_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/gyno.2002.6783","article-title":"Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with tamoxifen intake","volume":"86","author":"Garuti","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.04.004_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ygyno.2004.01.032","article-title":"The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow","volume":"93","author":"Develioglu","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.04.004_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0305-7372(97)90037-2","article-title":"Aromatase inhibitors and breast cancer","volume":"23","author":"Miller","year":"1997","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ygyno.2006.04.004_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1074-3804(05)60013-8","article-title":"Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer","volume":"11","author":"Garuti","year":"2004","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"10.1016\/j.ygyno.2006.04.004_bib13","article-title":"Biopsy pathology of the endometrium","volume":"vol. 14","author":"Burkley","year":"1989"},{"key":"10.1016\/j.ygyno.2006.04.004_bib14","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","article-title":"A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer","volume":"353","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"suppl 5","key":"10.1016\/j.ygyno.2006.04.004_bib15","article-title":"fewer endometrial abnormalities with anastrozole than tamoxifen: endometrial sub-protocol results from the ATAC early breast cancer trial in postmenopausal patients","volume":"13","author":"Duffy","year":"2002","journal-title":"Ann. Oncol."},{"issue":"suppl 4","key":"10.1016\/j.ygyno.2006.04.004_bib16","article-title":"Reversal of tamoxifen-induced endometrial modifications by switching to letrozole in early breast cancer patients: a prospective TVUS study","volume":"14","author":"Garrone","year":"2003","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2006.04.004_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/humrep\/deh567","article-title":"The ATAC (arimidex, tamoxifen, alone or in combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy","volume":"20","author":"Duffy","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ygyno.2006.04.004_bib18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humrep\/dei322","article-title":"The ATAC (\u2018Arimidex\u2019, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.","volume":"21","author":"Duffy","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ygyno.2006.04.004_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/annonc\/mdi021","article-title":"Third generation aromatase inhibitors may prevent and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients","volume":"16","author":"Morales","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2006.04.004_bib20","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1158\/1078-0432.CCR-05-0225","article-title":"Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology","volume":"12","author":"Gerber","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2006.04.004_bib21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1054\/brst.1999.0160","article-title":"Thickened endometrium caused by tamoxifen returns to normal following tamoxifen cessation","volume":"9","author":"Love","year":"2000","journal-title":"Breast"},{"key":"10.1016\/j.ygyno.2006.04.004_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejogrb.2004.07.002","article-title":"Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal women","volume":"118","author":"Agorastos","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ygyno.2006.04.004_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2005.03.036","article-title":"Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women","volume":"98","author":"Garuti","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.04.004_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0020-7292(99)00079-X","article-title":"Hysteroscopic evaluation of the endometrium of postmenopausal patients with breast cancer before and after tamoxifen use","volume":"66","author":"Goncalves","year":"1999","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ygyno.2006.04.004_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0029-7844(97)00591-7","article-title":"Uterine side effects of tamoxifen; a need for systematic pretreatment screening","volume":"91","author":"B\u00e8rliere","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2006.04.004_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0002-9378(95)90483-2","article-title":"Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding. A Nordic multicenter study","volume":"172","author":"Karlsson","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2006.04.004_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ctrv.2003.09.004","article-title":"The effects of tamoxifen on the female genital tract","volume":"30","author":"Senkus-Konefka","year":"2004","journal-title":"Cancer Treat Rev"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806003301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806003301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T05:58:37Z","timestamp":1555653517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825806003301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0090825806003301"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2006.04.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}